For the fourth quarter of 2025, Chemours posted adjusted earnings per share of $0.05, missing the consensus estimate of $0.07. Revenue totaled $1.3 billion, down 2% year over year and below the $1.33 ...

PTC ended the year with $1.95 billion in cash, cash equivalents and marketable securities, up from $1.14 billion at the end of 2024.

Total homes purchased rose 46% quarter-over-quarter, reflecting a renewed push to scale the platform after a period of retrenchment. Fixed operating expenses also declined to $35 million, suggesting ...

Investing.com -- Travere Therapeutics (NASDAQ: TVTX) reported a fourth-quarter profit that handily beat Wall Street expectations, driven by surging sales of its kidney disease therapy FILSPARI, though ...

JERUSALEM, Feb 19 (Reuters) - More than 75,000 Palestinians were killed in the first 15 months of Israel’s military assault ...

Looking ahead, Akamai guided for fiscal 2026 non-GAAP EPS of $6.20 to $7.20, below the $7.34 consensus estimate. The company expects full-year revenue of $4.4 billion to $4.55 billion and a non-GAAP ...

ABOARD AIR FORCE ONE, Feb 19 (Reuters) - President Donald Trump on Thursday accused former President Barack Obama of ...

Palo Alto Networks had a solid quarter with revenue growing by 15% to $2.59 billion. Growth has slowed from prior peaks but ...

Investing.com -- Johnson & Johnson is getting ready to sell its orthopedics unit, DePuy Synthes, which could be valued at more than $20 billion, according to a report from Bloomberg News, citing ...

Bank of America Corp, Alphabet Inc Class A, Apple Inc, Amazon.com Inc. Read 's Market Analysis on Investing.com ...

Investing.com -- CIBC economists Benjamin Tal and Katherine Judge have issued a sobering assessment of the nation’s housing ...

Neutrans files for upsized 3.75M share IPO at $4-$6/sh ...